Xintela achieves primary endpoint in knee osteoarthritis study and signs convertible loan of SEK 30 million
The company also reports positive results for knee osteoarthritis, is granted patents in the US and Japan, and concludes development roles.
Latest Xintela News & Updates
See the latest news and media coverage for Xintela. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company developing stem cell and targeted cancer therapies
xintela.se- Headquarters
- Lund, Sweden
- Founded year
- 2009
- Company type
- Public company
- Number of employees
- 18–50
- Industry
- Pharmaceuticals
Last updated
Latest news about Xintela
In short: Xintela met leg ulcer goal, reported osteoarthritis data, gained patents, and secured a 30 MSEK loan.
Company announcements
Xintela publishes results from knee osteoarthritis study with XSTEM in scientific journal
The results show reduced knee pain, improved joint function as well as improved cartilage and bone tissue, supporting a disease-modifying effect.
Xintela takes up convertible loan of SEK 30 million
The loan from main owner Flerie Invest will accelerate XSTEM development and repay previous loan.
Xintela reports positive safety results from clinical study with XSTEM
No serious adverse events were reported, and the company plans to evaluate XSTEM on other wound indications.
Media coverage
Reduced loss for Xintela
Xintela, which develops medical products within stem cell therapy and targeted cancer therapy, reports a pre-tax result of -9.8 million kronor...
Lund company granted US patent - "Confirms the strength of our stem cell technology"
Xintela, based in Lund, has been granted a patent in the USA for the stem cell therapy candidate Xstem, for the treatment of skin defects and hard-to-heal wounds.
Xintela AB: Xintela AB Year-end Report 2025
The "Company" or "Xintela" refers to Xintela AB (publ), corporate registration number 556780-3480. The Group Forth quarter 2025 Income amounted to TSEK 415 (1,090). Loss...
Xintela AB
Visit a quote page and your recently viewed tickers will be displayed here.
Never miss news about Xintela
Track Xintela and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Xintela competitors & trending companies
Browse news for competitors to Xintela and other trending companies.
Retro
NextCell
Imugene
Regentis Biomaterials
Fate Therapeutics
HELP Therapeutics
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon
Delphidata
Waystream
Netnod
Open Infra